EUVIMEDEUVIMED entdecken
Open Access

Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

Jessica R Allanach iD, Naomi M Fettig iD, Blair K Hardman iD, Ariel R Rosen, Vina Fan iD, Cynthia Chung iD, Erin J Goldberg, Zachary J Morse iD, Iryna Shanina, Galina Vorobeychik iD, Lisa C Osborne iD, Marc S Horwitz iD

Science Advances · 2025

DOI: 10.1126/sciadv.adu5110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Jessica R Allanach und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Multiple Sclerosis, Herpesvirus 4, Human, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Latent infection with Epstein-Barr virus (EBV) is a strong risk factor for the development of multiple sclerosis (MS), although the underlying mechanisms remain unclear. To investigate this association, we induced experimental autoimmune encephalomyelitis (EAE) in immunodeficient mice reconstituted with peripheral blood mononuclear cells (PBMCs) from individuals with or without a history of EBV infection and/or relapsing MS (RRMS). HuPBMC EAE mice generated from EBV-seronegative healthy donors were less susceptible to developing severe neurological symptoms than healthy EBV-seropositive and RRMS donor groups. Donor EBV seropositivity and RRMS diagnosis were associated with a significant increase in the number of central nervous system (CNS) infiltrating effector T cells due to enhanced proliferation of proinflammatory T cells and limited expansion of regulatory T cells. The data indicate that a history of EBV infection, further compounded by a diagnosis of RRMS, promotes T cell–mediated xenogeneic CNS disease in a humanized mouse model of MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsMultiple SclerosisHerpesvirus 4, HumanEncephalomyelitis, Autoimmune, ExperimentalT-LymphocytesAnimalsMiceHumansDisease Models, AnimalFemaleLeukocytes, Mononuclear

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.
  • Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada.
  • Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

ORCID-Profile: Jessica R Allanach, Naomi M Fettig, Blair K Hardman, Vina Fan, Cynthia Chung, Zachary J Morse, Galina Vorobeychik, Lisa C Osborne, Marc S Horwitz

Zitieren

APA

Allanach, J. R., Fettig, N. M., Hardman, B. K., Rosen, A. R., Fan, V., Chung, C., Goldberg, E. J., Morse, Z. J., Shanina, I., Vorobeychik, G., Osborne, L. C., & Horwitz, M. S. (2025). Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis. Science Advances. https://doi.org/10.1126/sciadv.adu5110

Vancouver

Allanach JR, Fettig NM, Hardman BK, Rosen AR, Fan V, Chung C, et al. Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis. Science Advances. 2025. doi:10.1126/sciadv.adu5110

BibTeX
@article{Allanach2025,
  author = {Allanach, Jessica R and Fettig, Naomi M and Hardman, Blair K and Rosen, Ariel R and Fan, Vina and Chung, Cynthia and Goldberg, Erin J and Morse, Zachary J and Shanina, Iryna and Vorobeychik, Galina and Osborne, Lisa C and Horwitz, Marc S},
  title = {Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adu5110}
}
Kostenlos starten →